ISDA

Entry Detail

PDB ID:

4S1G

Keywords:

Title:

Renin in complex with (S)-1-(3-fluoro-5-(((S)-1-phenylethyl)carbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1H)-iminium

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Homo sapiens

PDB Version:

Deposition Date:

2015-01-13

Release Date:

2015-02-25

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.10 Å

R-Value Free:

0.22

R-Value Work:

0.21

R-Value Observed:

0.21

Space Group:

P 21 3

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Renin
Chain IDs:A, B
Chain Length:340
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P00797 Pfam ID:PF00026 EC:3.4.23.15

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
ASN	B	ASN	GLYCOSYLATION SITE

Ligand Molecules

43T

NAG

Primary Citation

Iminopyrimidinones: A novel pharmacophore for the development of orally active renin inhibitors.

McKittrick, B.A, Caldwell, J.P, Bara, T, Boykow, G, Chintala, M, Clader, J, Czarniecki, M, Courneya, B, Duffy, R, Fleming, L, Giessert, R, Greenlee, W.J, Heap, C, Hong, L, Huang, Y, Iserloh, U, Josien, H, Khan, T, Korfmacher, W, Liang, X, Mazzola, R, Mitra, S, Moore, K, Orth, P, Rajagopalan, M, Roy, S, Sakwa, S, Strickland, C, Vaccaro, H, Voigt, J, Wang, H, Wong, J, Zhang, R, Zych, A.Show

Bioorg.Med.Chem.Lett. 25 1592 1596 (2015)

PMID: 25728416 DOI: 10.1016/j.bmcl.2015.02.003

Abstact

The development of renin inhibitors with favorable oral pharmacokinetic profiles has been a longstanding challenge for the pharmaceutical industry. As part of our work to identify inhibitors of BACE1, we have previously developed iminopyrimidinones as a novel pharmacophore for aspartyl protease inhibition. In this letter we describe how we modified substitution around this pharmacophore to develop a potent, selective and orally active renin inhibitor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures